{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T14:04:09Z","timestamp":1722693849564},"reference-count":86,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Asociaci\u00f3n Espa\u00f1ola de Mastocitosis y enfermedades relacionadas"},{"name":"Fondos de Investigaci\u00f3n para Enfermedades Raras del Ministerio de Sanidad"},{"name":"Servicios sociales e Igualdad"},{"name":"Ensayo cl\u00ednico independiente del Ministerio de Salud y Pol\u00edtica Social"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.iac.2018.04.012","type":"journal-article","created":{"date-parts":[[2018,7,14]],"date-time":"2018-07-14T16:42:47Z","timestamp":1531586567000},"page":"379-395","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Bone Marrow Expression of Mast Cell Disorders"],"prefix":"10.1016","volume":"38","author":[{"given":"Laura","family":"S\u00e1nchez-Mu\u00f1oz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Filipa","family":"Henriques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iv\u00e1n","family":"Alvarez-Twose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Almudena","family":"Matito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.iac.2018.04.012_bib1","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.iac.2018.04.012_bib2","series-title":"Pathology & genetics. Tumours of haematopoietic and lymphoid tissues","article-title":"Mastocytosis. World Health Organization (WHO) Classification of Tumours","author":"Horny","year":"2016"},{"issue":"11","key":"10.1016\/j.iac.2018.04.012_bib3","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1182\/blood-2016-09-731893","article-title":"Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts","volume":"129","author":"Valent","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.iac.2018.04.012_bib4","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jaci.2015.05.008","article-title":"Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis","volume":"137","author":"Alvarez-Twose","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"suppl","key":"10.1016\/j.iac.2018.04.012_bib5","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1111\/1523-1747.ep12468869","article-title":"Clinical advances in mastocytosis: an interdisciplinary roundtable discussion","volume":"96","author":"Metcalfe","year":"1991","journal-title":"J\u00a0Invest Dermatol"},{"issue":"3","key":"10.1016\/j.iac.2018.04.012_bib6","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000083954","article-title":"Indolent systemic mastocytosis with elevated serum tryptase, absence of skin lesions, and recurrent severe anaphylactoid episodes","volume":"136","author":"Florian","year":"2005","journal-title":"Int Arch Allergy Immunol"},{"issue":"6","key":"10.1016\/j.iac.2018.04.012_bib7","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jaci.2010.02.019","article-title":"Clinical, biological and molecular characteristics of systemic mast cell disorders presenting with severe mediator-related symptoms","volume":"125","author":"Alvarez-Twose","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2018.04.012_bib8","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000328760","article-title":"Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal","volume":"157","author":"Valent","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.iac.2018.04.012_bib9","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/(SICI)1097-0320(19970415)30:2<98::AID-CYTO4>3.0.CO;2-9","article-title":"Sequential immunophenotypic analysis of mast cells in a case of systemic mast cell disease evolving to a mast cell leukemia","volume":"30","author":"Escribano","year":"1997","journal-title":"Cytometry"},{"issue":"9","key":"10.1016\/j.iac.2018.04.012_bib10","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/modpathol.2011.84","article-title":"Evaluation of the WHO criteria for the classification of patients with mastocytosis","volume":"24","author":"S\u00e1nchez-Mu\u00f1oz","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.iac.2018.04.012_bib11","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jaci.2013.06.020","article-title":"Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM","volume":"133","author":"Alvarez-Twose","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2018.04.012_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cyto.b.10072","article-title":"Immunophenotypic analysis of mast cells in mastocytosis: when and how to do it. Proposals of the Spanish Network on Mastocytosis (REMA)","volume":"58B","author":"Escribano","year":"2004","journal-title":"Cytometry B Clin Cytom"},{"issue":"3","key":"10.1016\/j.iac.2018.04.012_bib13","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jaci.2009.10.020","article-title":"Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes","volume":"125","author":"Teodosio","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.iac.2018.04.012_bib14","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1182\/blood-2006-04-015545","article-title":"KIT mutation in mast cells and other bone marrow haematopoietic cell lineages in systemic mast cell disorders. A prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients","volume":"108","author":"Garcia-Montero","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.iac.2018.04.012_bib15","series-title":"Laboratory hematology practice","first-page":"388","article-title":"Diagnosis of adult mastocytosis: role for bone marrow analysis","author":"Escribano","year":"2012"},{"issue":"1","key":"10.1016\/j.iac.2018.04.012_bib16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/bjh.13789","article-title":"Diagnosis and classification of mastocytosis in non-specialized versus reference centres: a Spanish Network on Mastocytosis (REMA) study on 122 patients","volume":"172","author":"S\u00e1nchez-Mu\u00f1oz","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.iac.2018.04.012_bib17","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1182\/blood-2006-06-028100","article-title":"Demonstration of an aberrant mast cell population with clonal markers in a subset of patients with \"idiopathic\" anaphylaxis","volume":"110","author":"Akin","year":"2007","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.iac.2018.04.012_bib18","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000096442","article-title":"Diagnostic and subdiagnostic accumulation of mast cells in the bone marrow of patients with anaphylaxis: monoclonal mast cell activation syndrome","volume":"142","author":"Sonneck","year":"2006","journal-title":"Int Arch Allergy Immunol"},{"issue":"3","key":"10.1016\/j.iac.2018.04.012_bib19","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jaci.2008.11.018","article-title":"Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels","volume":"123","author":"Bonadonna","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.iac.2018.04.012_bib20","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/all.12126","article-title":"Mast cell activation syndromes: definition and classification","volume":"68","author":"Valent","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2018.04.012_bib21","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.12688\/f1000research.9565.1","article-title":"Advances in the understanding and clinical management of mastocytosis and clonal mast cell activation syndromes","volume":"5","author":"Gonzalez de Olano","year":"2016","journal-title":"F1000Res"},{"issue":"23","key":"10.1016\/j.iac.2018.04.012_bib22","doi-asserted-by":"crossref","first-page":"10560","DOI":"10.1073\/pnas.92.23.10560","article-title":"Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder","volume":"92","author":"Nagata","year":"1995","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"3","key":"10.1016\/j.iac.2018.04.012_bib23","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/ng0396-312","article-title":"Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm","volume":"12","author":"Longley","year":"1996","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.iac.2018.04.012_bib24","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1073\/pnas.96.4.1609","article-title":"Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis","volume":"96","author":"Longley","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.iac.2018.04.012_bib25","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1182\/blood-2002-01-0203","article-title":"Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c-kit gene","volume":"100","author":"Yavuz","year":"2002","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.iac.2018.04.012_bib26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2141.2007.06619.x","article-title":"Recent advances in the understanding of mastocytosis: the role of KIT mutations","volume":"138","author":"Orfao","year":"2007","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.iac.2018.04.012_bib27","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2362.2007.01807.x","article-title":"Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria","volume":"37","author":"Valent","year":"2007","journal-title":"Eur J Clin Invest"},{"issue":"7","key":"10.1016\/j.iac.2018.04.012_bib28","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0145-2126(01)00021-2","article-title":"Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings","volume":"25","author":"Horny","year":"2001","journal-title":"Leuk Res"},{"issue":"4","key":"10.1016\/j.iac.2018.04.012_bib29","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1590\/1516-3180.2013.1314590","article-title":"Diagnosis and treatment of mast cell disorders: practical recommendations","volume":"131","author":"Sandes","year":"2013","journal-title":"Sao Paulo Med J"},{"key":"10.1016\/j.iac.2018.04.012_bib30","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1751-553X.2012.01427.x","article-title":"Current state of biology and diagnosis of clonal mast cell diseases in adults","volume":"34","author":"Alvarez-Twose","year":"2012","journal-title":"Int J Lab Hematol"},{"issue":"2","key":"10.1016\/j.iac.2018.04.012_bib31","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.iac.2014.01.005","article-title":"Mastocytosis: immunophenotypical features of the transformed mast cells are unique among hematopoietic cells","volume":"34","author":"Horny","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"issue":"5","key":"10.1016\/j.iac.2018.04.012_bib32","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3109\/10428194.2011.561389","article-title":"Mastocytosis: the new differential diagnosis of CD30-positive neoplasms","volume":"52","author":"Maric","year":"2011","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"10.1016\/j.iac.2018.04.012_bib33","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/modpathol.2010.224","article-title":"Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosis","volume":"24","author":"Sotlar","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.iac.2018.04.012_bib34","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0145-2126(01)00041-8","article-title":"Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis","volume":"25","author":"Sperr","year":"2001","journal-title":"Leuk Res"},{"issue":"12","key":"10.1016\/j.iac.2018.04.012_bib35","doi-asserted-by":"crossref","first-page":"e126","DOI":"10.1200\/JCO.2011.38.9973","article-title":"Complete response after imatinib mesylate therapy in a patient with well-differentiated systemic mastocytosis","volume":"30","author":"Alvarez-Twose","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.iac.2018.04.012_bib36","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/mi.2009.136","article-title":"Advances in mast cell biology: new understanding of heterogeneity and function","volume":"3","author":"Moon","year":"2010","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.iac.2018.04.012_bib37","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/B978-0-12-385493-3.00014-0","article-title":"Immunophenotypic characterization of bone marrow mast cells in mastocytosis and other mast cell disorders","volume":"103","author":"S\u00e1nchez-Mu\u00f1oz","year":"2011","journal-title":"Methods Cell Biol"},{"issue":"3","key":"10.1016\/j.iac.2018.04.012_bib38","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.iac.2006.05.008","article-title":"Flow cytometric analysis of normal and neoplastic mast cells: role in diagnosis and follow-up of mast cell disease","volume":"26","author":"Escribano","year":"2006","journal-title":"Immunol Allergy Clin North Am"},{"issue":"2","key":"10.1016\/j.iac.2018.04.012_bib39","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.iac.2014.01.008","article-title":"Flow cytometry in mastocytosis: utility as a diagnostic and prognostic tool","volume":"34","author":"S\u00e1nchez-Mu\u00f1oz","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"issue":"4","key":"10.1016\/j.iac.2018.04.012_bib40","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1177\/039463200802100404","article-title":"CD203c is overexpressed on neoplastic mast cells in systemic mastocytosis and is upregulated upon IgE receptor cross-linking","volume":"21","author":"Hauswirth","year":"2008","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.iac.2018.04.012_bib41","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3109\/10428199809057558","article-title":"Expression of the c-kit (CD117) molecule in normal and malignant hematopoiesis","volume":"30","author":"Escribano","year":"1998","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.iac.2018.04.012_bib42","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000235115","article-title":"Further characterization of surface membrane structures expressed on human basophils and mast cells","volume":"91","author":"Valent","year":"1990","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"10.1016\/j.iac.2018.04.012_bib43","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0065-2776(08)60879-2","article-title":"Cell surface structures on human basophils and mast cells: biochemical and functional characterization","volume":"52","author":"Valent","year":"1992","journal-title":"Adv Immunol"},{"key":"10.1016\/j.iac.2018.04.012_bib44","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0145-2126(01)00050-9","article-title":"Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis","volume":"25","author":"Escribano","year":"2001","journal-title":"Leuk Res"},{"issue":"2","key":"10.1016\/j.iac.2018.04.012_bib45","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000048183","article-title":"Abnormal expression of CD antigens in mastocytosis","volume":"127","author":"Escribano","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"issue":"2","key":"10.1016\/j.iac.2018.04.012_bib46","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1046\/j.1468-3083.2003.00603.x","article-title":"Indolent systemic mast cell disease: immunophenotypic characterization of bone marrow mast cells by flow cytometry","volume":"17","author":"Bodni","year":"2003","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"8","key":"10.1016\/j.iac.2018.04.012_bib47","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.leukres.2003.10.035","article-title":"Bone marrow mast cell immunophenotyping in adults with mast cell disease: a prospective study of 33 patients","volume":"28","author":"Pardanani","year":"2004","journal-title":"Leuk Res"},{"issue":"8","key":"10.1016\/j.iac.2018.04.012_bib48","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1182\/blood.V91.8.2731.2731_2731_2736","article-title":"Indolent systemic mast cell disease in adults: immunophenotypic characterization of bone marrow mast cells and its diagnostic implications","volume":"91","author":"Escribano","year":"1998","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.iac.2018.04.012_bib49","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/modpathol.2011.192","article-title":"Immunophenotyping in systemic mastocytosis diagnosis: 'CD25 positive' alone is more informative than the 'CD25 and\/or CD2' WHO criterion","volume":"25","author":"Morgado","year":"2012","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.iac.2018.04.012_bib50","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1046\/j.1365-2141.1999.01572.x","article-title":"The CD69 early activation molecule is overexpressed in human bone marrow mast cells from adults with indolent systemic mast cell disease","volume":"106","author":"Diaz-Agustin","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.iac.2018.04.012_bib51","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/(SICI)1097-0320(19981015)34:5<223::AID-CYTO3>3.0.CO;2-B","article-title":"Human bone marrow mast cells from indolent systemic mast cell disease constitutively express increased amounts of the CD63 protein on their surface","volume":"34","author":"Escribano","year":"1998","journal-title":"Cytometry"},{"key":"10.1016\/j.iac.2018.04.012_bib52","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1155\/1998\/341340","article-title":"Immunophenotypic characterization of human bone marrow mast cells. A flow cytometric study of normal and pathological bone marrow samples","volume":"16","author":"Escribano","year":"1998","journal-title":"Annal Cell Pathol"},{"key":"10.1016\/j.iac.2018.04.012_bib53","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1365-2141.2003.04055.x","article-title":"Overexpression of complement receptors and related antigens on the surface of bone marrow mast cells in patients with systemic mastocytosis","volume":"120","author":"Nu\u00f1ez","year":"2002","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.iac.2018.04.012_bib54","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/his.12221","article-title":"CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis","volume":"63","author":"Morgado","year":"2013","journal-title":"Histopathology"},{"issue":"5","key":"10.1016\/j.iac.2018.04.012_bib55","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/leu.2011.293","article-title":"An immature immunophenotype of bone marrow mast cells predicts for multilineage D816V KIT mutation in systemic mastocytosis","volume":"26","author":"Teodosio","year":"2012","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.iac.2018.04.012_bib56","doi-asserted-by":"crossref","first-page":"S327","DOI":"10.1016\/j.jaci.2004.01.683","article-title":"Well-differentiated systemic mastocytosis: a new disease variant with mature mast cell phenotype and lack of codon 816 c-Kit mutations","volume":"113","author":"Akin","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2018.04.012_bib57","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jaci.2009.05.003","article-title":"Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients","volume":"124","author":"Escribano","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"23","key":"10.1016\/j.iac.2018.04.012_bib58","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.1182\/blood-2009-02-205237","article-title":"Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors","volume":"113","author":"Lim","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.iac.2018.04.012_bib59","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","article-title":"Diagnostic criteria and classification of mastocytosis: a consensus proposal","volume":"25","author":"Valent","year":"2001","journal-title":"Leuk Res"},{"issue":"6","key":"10.1016\/j.iac.2018.04.012_bib60","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/leu.2008.49","article-title":"The immunophenotype of different immature, myeloid and B-cell lineage-committed CD34+ hematopoietic cells allows discrimination between normal\/reactive and myelodysplastic syndrome precursors","volume":"22","author":"Matarraz","year":"2008","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.iac.2018.04.012_bib61","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/j.1398-9995.2005.00865.x","article-title":"Detection of differentiation- and activation-linked cell surface antigens on cultured mast cell progenitors","volume":"60","author":"Schernthaner","year":"2005","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.iac.2018.04.012_bib62","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0002-9440(10)63870-9","article-title":"One-step detection of c-kit point mutations using PNA-mediated PCR-clamping and hybridization probes","volume":"162","author":"Sotlar","year":"2003","journal-title":"Am J Pathol"},{"issue":"supplement 1","key":"10.1016\/j.iac.2018.04.012_bib63","first-page":"91","article-title":"Well-differentiated systemic mastocytosis (WDSM): a novel form of mastocytosis","volume":"93","author":"Jara-Acevedo","year":"2008","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.iac.2018.04.012_bib64","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.exphem.2011.05.009","article-title":"Novel, activating KIT-N822I mutation in familial cutaneous mastocytosis","volume":"39","author":"Wasag","year":"2011","journal-title":"Exp Hematol"},{"issue":"1","key":"10.1016\/j.iac.2018.04.012_bib65","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/ajh.10322","article-title":"Systemic mastocytosis with associated clonal Hematological non-mast-cell lineage disease: analysis of clinicopathologic features and activating c-kit mutations","volume":"73","author":"Pullarkat","year":"2003","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.iac.2018.04.012_bib66","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1046\/j.1365-2141.1997.d01-2042.x","article-title":"A\u00a0new c-kit mutation in a case of aggressive mast cell disease","volume":"96","author":"Pignon","year":"1997","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.iac.2018.04.012_bib67","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1182\/blood-2003-11-3816","article-title":"A\u00a0novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib","volume":"103","author":"Akin","year":"2004","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.iac.2018.04.012_bib68","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/labmed\/lmx026","article-title":"R634W KIT mutation in an adult with systemic mastocytosis","volume":"48","author":"Astle","year":"2017","journal-title":"Lab Med"},{"key":"10.1016\/j.iac.2018.04.012_bib69","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13223-017-0193-x","article-title":"Systemic mastocytosis with KIT V560G mutation presenting as recurrent episodes of vascular collapse: response to disodium cromoglycate and disease outcome","volume":"13","author":"Conde-Fernandes","year":"2017","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2018.04.012_bib70","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/pde.12381","article-title":"Novel R634W c-kit mutation identified in familial mastocytosis","volume":"32","author":"Pollard","year":"2015","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"10.1016\/j.iac.2018.04.012_bib71","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1136\/jmg.2003.015156","article-title":"A\u00a0germline mutation in KIT in familial diffuse cutaneous mastocytosis","volume":"41","author":"Tang","year":"2004","journal-title":"J\u00a0Med Genet"},{"issue":"2","key":"10.1016\/j.iac.2018.04.012_bib72","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/ced.12225","article-title":"A\u00a0new germline mutation in KIT associated with diffuse cutaneous mastocytosis in a Chinese family","volume":"39","author":"Wang","year":"2014","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"10.1016\/j.iac.2018.04.012_bib73","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/jid.2012.394","article-title":"A\u00a0c-kit mutation in exon 18 in familial mastocytosis","volume":"133","author":"Wohrl","year":"2013","journal-title":"J\u00a0Invest Dermatol"},{"issue":"4","key":"10.1016\/j.iac.2018.04.012_bib74","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.leukres.2005.08.015","article-title":"A\u00a0novel K5091 mutation of KIT identified in familial mastocytosis - in\u00a0vitro and in\u00a0vivo responsiveness to imatinib therapy","volume":"30","author":"Zhang","year":"2006","journal-title":"Leuk Res"},{"issue":"6","key":"10.1016\/j.iac.2018.04.012_bib75","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/leu.2015.24","article-title":"KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis","volume":"29","author":"Arock","year":"2015","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.iac.2018.04.012_bib76","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.jaci.2005.02.030","article-title":"Analysis of the lineage relationship between mast cells and basophils using the c-kit D816V mutation as a biologic signature","volume":"115","author":"Kocabas","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"11\u201312","key":"10.1016\/j.iac.2018.04.012_bib77","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00251-010-0474-8","article-title":"Comparative analysis of mutation of tyrosine kinase kit in mast cells from patients with systemic mast cell activation syndrome and healthy subjects","volume":"62","author":"Molderings","year":"2010","journal-title":"Immunogenetics"},{"issue":"10","key":"10.1016\/j.iac.2018.04.012_bib78","doi-asserted-by":"crossref","first-page":"e76116","DOI":"10.1371\/journal.pone.0076116","article-title":"Serum tryptase monitoring in indolent systemic mastocytosis: association with disease features and patient outcome","volume":"8","author":"Matito","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.iac.2018.04.012_bib79","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0301-472X(99)00145-9","article-title":"Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T\u00a0cells, B cells, and myelomonocytic cells in patients with mastocytosis","volume":"28","author":"Akin","year":"2000","journal-title":"Exp Hematol"},{"issue":"8","key":"10.1016\/j.iac.2018.04.012_bib80","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/modpathol.2015.72","article-title":"Detection of the KIT D816V mutation in peripheral blood of systemic mastocytosis: diagnostic implications","volume":"28","author":"Jara-Acevedo","year":"2015","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.iac.2018.04.012_bib81","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/all.12409","article-title":"The KIT D816V allele burden predicts survival in patients with mastocytosis and correlates with the WHO type of the disease","volume":"69","author":"Hoermann","year":"2014","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.iac.2018.04.012_bib82","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jmoldx.2010.10.004","article-title":"Improved detection of the KIT D816V mutation in patients with systemic mastocytosis using a quantitative and highly sensitive real-time qPCR assay","volume":"13","author":"Kristensen","year":"2011","journal-title":"J\u00a0Mol Diagn"},{"issue":"5","key":"10.1016\/j.iac.2018.04.012_bib83","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/ajh.23672","article-title":"Sensitive KIT D816V mutation analysis of blood as a diagnostic test in mastocytosis","volume":"89","author":"Kristensen","year":"2014","journal-title":"Am J Hematol"},{"key":"10.1016\/j.iac.2018.04.012_bib84","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/all.12436","article-title":"Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis","volume":"69","author":"Valent","year":"2014","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.iac.2018.04.012_bib85","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00277-013-1964-1","article-title":"The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosis","volume":"93","author":"Erben","year":"2014","journal-title":"Ann Hematol"},{"key":"10.1016\/j.iac.2018.04.012_bib86","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3109\/10428199909145725","article-title":"Immunophenotype of bone marrow mast cells in indolent systemic mast cell disease in adults","volume":"35","author":"Escribano","year":"1999","journal-title":"Leuk Lymphoma"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856118300407?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856118300407?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,20]],"date-time":"2019-10-20T20:57:21Z","timestamp":1571605041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856118300407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":86,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0889856118300407"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2018.04.012","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone Marrow Expression of Mast Cell Disorders","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2018.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}